Final Meaningful Use Objectives for 2017

Similar documents
Final Meaningful Use Objectives for

Final Meaningful Use Objectives for

EHR Incentive Programs for Eligible Professionals: What You Need to Know for 2016 Tipsheet

FINAL Meaningful Use Objectives for

Meaningful Use - Modified Stage Alternate Exclusions and/or Specifications

EHR Incentive Programs: 2015 through 2017 (Modified Stage 2) Overview

2018 Modified Stage 3 Meaningful Use Criteria for Eligible Professionals (EPs)*

Medicare and Medicaid EHR Incentive Program. Stage 3 and Modifications to Meaningful Use in 2015 through 2017 Final Rule with Comment

Meaningful Use - Modified Stage 2. Brett Paepke, OD David Wolfson Marni Anderson

MEANINGFUL USE 2015 PROPOSED 2015 MEANINGFUL USE FLEXIBILITY RULE

Meaningful Use CHCANYS Webinar #1

Meaningful Use What You Need to Know for December 6, 2016

Meaningful Use Virtual Office Hours Webinar for Eligible Providers and Hospitals

of 23 Meaningful Use 2015 PER THE CMS REVISION TO THE FINAL RULE RELEASED OCTOBER 6, 2015 CHARTMAKER MEDICAL SUITE

STAGE 2 PROPOSED REQUIREMENTS FOR MEETING MEANINGFUL USE OF EHRs 1

EHR/Meaningful Use

during the EHR reporting period.

Meaningful Use 2016 and beyond

Eligible Professional Attestation Worksheet for Modified Stage 2 Medicare Electronic Health Record (EHR) Incentive Program

2015 MEANINGFUL USE STAGE 2 FOR ELIGIBLE PROVIDERS USING CERTIFIED EMR TECHNOLOGY

Meaningful Use and PCC EHR. Tim Proctor Users Conference 2017

MEANINGFUL USE STAGE 2

Medicaid EHR Incentive Program What You Need to Know about Program Year 2016

Ophthalmology Meaningful Use Attestation Guide 2016 Edition Updated July 2016

Appendix 4 CMS Stage 1 Meaningful Use Requirements Summary Tables 4-1 APPENDIX 4 CMS STAGE 1 MEANINGFUL USE REQUIREMENTS SUMMARY

PROPOSED MEANINGFUL USE STAGE 2 REQUIREMENTS FOR ELIGIBLE PROVIDERS USING CERTIFIED EMR TECHNOLOGY

MEANINGFUL USE STAGE FOR ELIGIBLE PROVIDERS USING CERTIFIED EMR TECHNOLOGY

Meaningful Use Stage 2

Alaska Medicaid Program

Meaningful Use Reporting period for 2017: Change: Any consecutive 90 days in 2017 for Medicaid customers only.

CMS Meaningful Use Proposed Rules Overview May 5, 2015

Stage 2 Eligible Professional Meaningful Use Core and Menu Measures. User Manual/Guide for Attestation using encompass 3.0

2015 Meaningful Use and emipp Updates (for Eligible Professionals)

Meaningful Use Hello Health v7 Guide for Eligible Professionals. Stage 2

THE MEANING OF MEANINGFUL USE CHANGES IN THE STAGE 2 MU FINAL RULE. Angel L. Moore, MAEd, RHIA Eastern AHEC REC

Final Meaningful Use Rules Add Short-Term Flexibility

Stage 1 Changes Tipsheet Last Updated: August, 2012

The History of Meaningful Use

PBSI-EHR Off the Charts Meaningful Use in 2016 The Patient Engagement Stage

Meaningful Use Modified Stage 2 Roadmap Eligible Hospitals

Meaningful Use and Care Transitions: Managing Change and Improving Quality of Care

Beyond Meaningful Use: Driving Improved Quality. CHCANYS Webinar #1: December 14, 2016

CHIME Concordance Analysis of Stage 2 Meaningful Use Final Rule - Objectives & Measures

Practice Director Modified Stage MU Guide 03/17/2016

Stage 2 Meaningful Use Objectives and Measures

Stage 1 Meaningful Use Objectives and Measures

2016 MEANINGFUL USE AND 2017 CHANGES to the Medicare EHR Incentive Program for EPs. September 27, 2016 Kathy Wild, Lisa Sagwitz, and Joe Pinto

Meaningful Use: Review of Changes to Objectives and Measures in Final Rule

Meaningful Use Overview for Program Year 2017 Massachusetts Medicaid EHR Incentive Program

Meaningful Use Measures: Quick Reference Guide Stage 2 (2014 and Beyond)

MIPS Program: 2017 Advancing Care Information Category (formerly known as Meaningful Use) Proposed Rule Guide

MIPS Program: 2018 Advancing Care Information Category

How to Participate Today 4/28/2015. HealthFusion.com 2015 HealthFusion, Inc. 1. Meaningful Use Stage 3: What the Future Holds

Prime Clinical Systems, Inc

Computer Provider Order Entry (CPOE)

New Hampshire Guidelines for Program Year 2016: Meaningful Use and Clinical Quality Measure Supporting Documents

Webinar #5 Meaningful Use: Looking Ahead to Stage 2 and CPS 12

Transforming Health Care with Health IT

Medicaid EHR Incentive Program Health Information Exchange Objective Stage 3 Updated: February 2017

Core Measure Set. Status. MU1 Increase from 30% New. Computerized Physician Order Entry Use computerized provider order. NextGen EHR Medication Module

Advancing Care Information Measures Data Validation Criteria. Reporting Requirement: Yes/No or Numerator/Denominator

CMS EHR Incentive Programs in 2015 through 2017 Overview

Welcome to the MS State Level Registry Companion Guide for

Meaningful Use Update: Stage 3 and Beyond. Carla McCorkle, Midas+ Solutions CQM Product Lead

Meaningful Use Hello Health v7 Guide for Eligible Professionals. Stage 1

APPENDIX 2 NCQA PCMH 2011 AND CMS STAGE 1 MEANINGFUL USE REQUIREMENTS

2017 Transition Year Flexibility Advancing Care Information (ACI) Category Options

Eligible Professionals (EP) Meaningful Use Final Objectives and Measures for Stage 1, 2011

Medicaid Provider Incentive Program

THE ECONOMICS OF MEDICAL PRACTICE UNDER HIPAA/HITECH

Game Plan. Meaningful Use Where are We? So is Anyone Registering? So, are EPs getting any money? $31,968,176,183

Overview of the EHR Incentive Program Stage 2 Final Rule published August, 2012

Measures Reporting for Eligible Hospitals

Agenda 2. EHR Incentive Programs 3/5/2015. Overview EHR incentive programs Meaningful Use Differences between Stage 1 and Stage 2

Meaningful Use and PCC EHR

Measures Reporting for Eligible Providers

Eligible Professionals. How can the West Virginia Health Information Network (WVHIN) assist you in meeting Meaningful Use requirements?

American Recovery & Reinvestment Act

Eligibility. Program Structure and Process for Receiving Incentives

Meaningful Use Basics and Attestation Process Guide for Medicare and Medi-Cal. Lori Hack & Val Tuerk, Object Health

Meaningful Use Modified Stage 2 Roadmap Eligible Professionals

EHR Meaningful Use Guide

2016 Meaningful Use Requirements Webinar - Transcript

Medicare & Medicaid EHR Incentive Programs. Stage 2 Final Rule Travis Broome AMIA

Meaningful Use: Today and in the Future VMGMA Spring Conference Richmond, VA March 21, 2016

Stage 3 and ACI s Relationship to Medicaid MU Massachusetts Medicaid EHR Incentive Program

Qualifying for Medicare Incentive Payments with Crystal Practice Management. Version 1.0

Meaningful Use and How it Relates to the Quality Payment Program. Erin Dormaier, CHTS-IM, PCMH CCE Transformation Support Services Manager

Updates to the EHR Incentive Programs Jason Felts, MS, CSCS HIT Practice Advisor

Meaningful Use Stage 2 For Eligible and Critical Access Hospitals

Recent and Proposed Rule Changes for Meaningful Use

Sevocity v Advancing Care Information User Reference Guide

Meaningful Use Stages 1 & 2

MACRA and MIPS. How Medicare Meaningful Use and PQRS are Changing

in partnership with EHR Meaningful Use Guide for HITECH Attestation

Eligible Professional Core Measure Frequently Asked Questions

Meaningful Use Participation Basics for the Small Provider

Meaningful Use May, 2012

Part 3: NCQA PCMH 2014 Standards

Copyright. Last updated: September 28, 2017 MicroMD EMR Objective Measure Calculations Manual: Performance Year 2017

Transcription:

Final Meaningful Use Objectives Modified Stage 2 All Eligible Professionals (EP) must attest to all objectives using a 2014 Edition or a combination of 2014 & 2015 CEHRT. Stage 2 Objective Protect Health Information Clinical Decision Support (CDS) Stage 2 Objective Description Protect electronic health information created or maintained by the CEHRT through the implementation of appropriate technical capabilities. Use clinical decision support to improve performance on highpriority health conditions. Measure Amount Yes/No 5 CDS interventions related to at least 4 CQMs/ Yes/No Stage 2 Measure(s) Exclusion(s) 2017 Alternate Objective, Measure or Exclusion 2 Conduct or review a security risk analysis in accordance with the requirements in 45 CFR 164.309(a)(1), including addressing the security (to include encryption of ephi created or maintained by CEHRT in accordance with requirements in 45 CFR 164.312(a)(2)(iv) and 45 CFR 164.306(d)(3), and implement security updates as necessary and correct identified security deficiencies as part of the EP s risk management process. Measure 1: Measure 2 Exclusion: Implement five (5) clinical decision Any EP who writes fewer than 100 support interventions related to medication orders during the EHR four or more (4+) clinical quality measures at a relevant point in patient care for the entire EHR Absent four (4) clinical quality measures related to an EP s scope of practice or patient population, the clinical decision support interventions must be related to high-priority health conditions.

Computerized Provider Order Entry (CPOE) Prescribing Use computerized provider order entry for medication, laboratory, and radiology orders directly entered by any licensed healthcare professional who can enter orders into the medical record per state, local and professional guidelines. Generate and transmit permissible prescriptions electronically (erx). The EP has enabled and implemented the functionality for drug-drug and drug-allergy interaction checks for the entire EHR 60%/30%/30% Measure 1: More than 60% of medication orders created by the EP or during the EHR reporting period are recorded using CPOE. More than 30% of laboratory orders created by the EP during the EHR reporting period are recorded using CPOE. Measure 3: More than 30% of radiology orders created by the EP during the EHR reporting period are recorded using CPOE. 50% More than 50% of all permissible prescriptions, written by the EP are queried for a drug formulary are transmitted electronically using CEHRT. Measure 1 Exclusion: Any EP who writes fewer than 100 medication orders during the EHR Measure 2 Exclusion: Any EP who writes fewer than 100 laboratory orders during the EHR Measure 3 Exclusion: Any EP who writes fewer than 100 radiology orders during the EHR Any EP who: 1. Writes fewer than 100 permissible prescriptions during the EHR reporting period; or 2. Does not have a pharmacy within his or her organization and there are no pharmacies that accept electronic prescriptions within 10 miles of the EP s practice location at the start of his or her EHR

Health Information Exchange (new name for PY2017) Patient Specific Education Medication Reconciliation Patient Access The EP who transitions their patient to another setting of care or provider of care or refers their patient to another provider of care provides a summary care record for each transition of care or referral. Use clinically relevant information from CEHRT to identify patientspecific education resources and provide those resources to the patient. The EP that receives a patient from another setting of care or provider of care or believes an encounter is relevant performs medication reconciliation. Provide patients the ability to view online, download, and transmit their health information within four (4) business days of the information being available to the EP 10% The EP that transitions or refers their patient to another setting of care or provider of care must- 1) Use CEHRT to create a summary of care record; and 2) electronically transmits such summary to a receiving provider for more than 10% of transitions of care and referrals. 10% Patient-specific education resources identified by CEHRT are provided to patients for more than 10% of all unique patients with office visits seen by the EP during the EHR 50% The EP performs medication reconciliation for more than 50% of transitions of care in which the patient is transitioned into the care of the EP. 50%/5% Measure 1: More than 50% of all unique patients seen by the EP during the EHR reporting period are provided timely access to view online, download, and transmit to a third party their health information subject to the EP s discretion to withhold certain information. EP Exclusion: Any EP who transfers a patient to another setting or refers a patient to another provider less than 100 times during the EHR Any EP who has no office visits during the EHR Any EP who was not the recipient of any transitions of care during the EHR Any EP who: Measure 1: Any EP who neither orders nor creates any of the information listed for inclusion as part of the measures except for Patient Name and Provider s name and office contact information. Any EP who:

For an EHR reporting period in 2017, more than 5 percent of unique patients seen by the EP during the EHR reporting period (or his or her authorized representatives) view, download or transmit to a third party their health information during the EHR Neither orders nor creates any of the information listed for inclusion as part of the measures except for Patient Name and Provider s name and office contact information; or Conducts 50 percent or more of his or her patient encounters in a county that does not have 50 percent or more of its housing units with 4Mbps broadband availability according to the latest information available from the FCC on the first day of the EHR Secure Messaging Public Health Reporting Use secure electronic messaging to communicate with patients on relevant health information. The EP is in active engagement with a public health agency to submit electronic public health data from CEHRT except where prohibited 5% For an EHR reporting period in 2017, for more than 5 percent of unique patients seen by the EP during the EHR reporting period, a secure message was sent using the electronic messaging function of CEHRT to the patient (or the patient-authorized representative), or in response to a secure message sent by the patient (or the patient-authorized representative) during the EHR Must meet the thresholds for at least two measures to meet the objective. Active Engagement is 1. Completed registration to submit data, 2. Testing and validation, or 3. Production Any EP who has no office visits during the EHR reporting period, or any EP who conducts 50 percent or more of his or her patient encounters in a county that does not have 50 percent or more of its housing units with 4Mbps broadband availability according to the latest information available from the FCC on the first day of the EHR Measure 1 Exclusions 1. Any EP that does not administer any immunizations to any of the populations for which data is collected by the jurisdiction s

and in accordance with applicable law and practice. EPs may report to more than one specialized registry and may count specialized registry reporting more than once to meet the required number of measures for the objective. Measure 1 Immunization Registry Reporting: The EP is in active engagement with a PHA to submit immunization data. Measure 2 Syndromic Surveillance Reporting: EP is in active engagement with a PHA to submit syndromic surveillance data. Measure 3 Specialized Registry Reporting: The EP is in active engagement to submit data to a specialized registry. immunization registry or IIS during the EHR reporting period, 2. Any EP that operates in a jurisdiction for which no immunization registry or IIS is capable of accepting the specific standards required to meet the CEHRT definition at the start of the EHR reporting period, or 3. Any EP that operates in a jurisdiction where no immunization registry or IIS has declared readiness to receive immunization data from the EP at the start of the EHR reporting period. Measure 2 Exclusions: 1. Any EP that is not in a category of providers from which ambulatory syndromic surveillance data is collected by their jurisdiction's syndromic surveillance system; 2. Any EP that operates in a jurisdiction for which PHA is capable of receiving electronic syndromic surveillance data from EPs in the specific standards required to meet the CEHRT definition at the start of the EHR reporting period; or 3. Any EP that operates in a jurisdiction where no PHA has declared readiness to receive syndromic surveillance data from

EPs at the start of the EHR Measure 3 Exclusions: Any EP meeting at least one of the following criteria may be excluded from the specialized registry reporting measure if the EP 1. Does not diagnose or treat any disease or condition associated with or collect relevant data that is required by a specialized registry in their jurisdiction during the EHR reporting period; 2. Operates in a jurisdiction for which no specialized registry is capable of accepting electronic registry transactions in the specific standards required to meet the CEHRT definition at the start of the EHR reporting period; or 3. Operates in a jurisdiction where no specialized registry for which the EP is eligible has declared readiness to receive electronic registry transactions at the beginning of the EHR reporting period